Trials / Completed
CompletedNCT02341638
Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects
Randomized, Double-Blinded, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 148 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a single and multiple oral doses of BMS-986141 in healthy subjects.
Detailed description
Maximum Age: Part A SAD 65 years Part B MAD 75 years Part C MAD Japanese 75 years
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986141 | |
| DRUG | Placebo | |
| DRUG | Aspirin | |
| DRUG | Itraconazole |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-01-19
- Last updated
- 2017-03-31
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02341638. Inclusion in this directory is not an endorsement.